Cipla Q4FY21 net profit up 73% at Rs 412 cr; company board recommends Rs 5 dividend for FY21

Drug major Cipla on Friday today posted 73 per cent rise in consolidated net profit at Rs 412 crore for the fourth quarter ended March 31, 2021 on the back of robust sales across markets. The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2019-20

The total revenues from operations rose to Rs 4,606 crore as compared with Rs 4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing. Source: Reuters

Drug major Cipla on Friday today posted 73 per cent rise in consolidated net profit at Rs 412 crore for the fourth quarter ended March 31, 2021 on the back of robust sales across markets. The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2019-20.

The total revenues from operations rose to Rs 4,606 crore as compared with Rs 4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing.

See Zee Business Live TV Streaming Below:

TRENDING NOW

As for the entire 2020-21 fiscal year, the drug maker reported a consolidated net profit of Rs 2,389 crore as against Rs 1,500 crore in the previous year.

Total revenue from operations for the last fiscal year rose to Rs 19,160 crore as against Rs 17,132 crore in 2019-20.

The company's board recommended a final dividend of Rs 5 per share (face value Rs 2 each) for 2020-21.

The Board of Directors of the Company at its meeting held on 14 May 2021 has recommended a final dividend of Rs 5 per equity share for the financial year ended 31 March, 2021, the company said in the exchange filing. The dividend is subject to approval at the ensuing annual general meeting of the Company, it further said.

The total income stood at Rs 4666 cr in the reporting quarter as against Rs 4469 cr in the corresponding quarter in FY20.

Shares of Cipla ended at Rs 904 on Friday on the NSE, going up by almost 0.6 per cent from the previous closing price on Thursday.

TAGS: